Evidence map›Paper›PMID 37463152›Full record

ArticlePLoS pathogens2023

14th century Yersinia pestis genomes support emergence of pestis secunda within Europe.

Cody E Parker, Alina N Hiss, Maria A Spyrou, Gunnar U Neumann, Philip Slavin, Elizabeth A Nelson, Sarah Nagel, Xandra Dalidowski, Susanne Friederich, Johannes Krause and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Ancient DNA and Human Physiology.Physiology (Bethesda, Md.) · 2026
    Review
  2. A refined phylochronology of the second plague pandemic in Western Eurasia.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Review
  5. Molecular Tracing and Comparative Genomics Analysis ofPathogens (Basel, Switzerland) · 2025
    Article
  6. Pandemics past, present, and future: progress and persistent risks.The Journal of clinical investigation · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Cody E ParkerMax Planck Institute for the Science of Human History, Jena, Germany.
Alina N HissMax Planck Institute for the Science of Human History, Jena, Germany.
Maria A SpyrouMax Planck Institute for the Science of Human History, Jena, Germany.
Gunnar U NeumannMax Planck Institute for the Science of Human History, Jena, Germany.
Philip SlavinDivision of History, Heritage and Politics, University of Stirling, Stirling, Scotland, United Kingdom.
Elizabeth A NelsonMax Planck Institute for the Science of Human History, Jena, Germany.
Sarah NagelMax Planck Institute for Evolutionary Anthropology, Leipzig, Germany.
Xandra DalidowskiLandesamt für Denkmalpflege und Archäologie, Sachsen-Anhalt, Halle (Saale), Germany.
Susanne FriederichLandesamt für Denkmalpflege und Archäologie, Sachsen-Anhalt, Halle (Saale), Germany.
Johannes KrauseMax Planck Institute for the Science of Human History, Jena, Germany.ORCID 0000-0001-9144-3920
Alexander HerbigMax Planck Institute for the Science of Human History, Jena, Germany.ORCID 0000-0003-1176-1166
Wolfgang HaakMax Planck Institute for the Science of Human History, Jena, Germany.ORCID 0000-0003-2475-2007
Kirsten I BosMax Planck Institute for the Science of Human History, Jena, Germany.ORCID 0000-0003-2937-3006
Max Planck Institute for Evolutionary Anthropology · DELandesamt für Denkmalpflege und Archäologie Sachsen-Anhalt · DEMax Planck Institute for the Science of Human History · DEUniversity of Stirling · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pestis secunda (1356-1366 CE) is the first of a series of plague outbreaks in Europe that followed the Black Death (1346-1353 CE). Collectively this period is called the Second Pandemic. From a genomic perspective, the majority of post-Black Death strains of Yersinia pestis thus far identified in Europe display diversity accumulated over a period of centuries that form a terminal sub-branch of the Y. pestis phylogeny. It has been debated if these strains arose from local evolution of Y. pestis or if the disease was repeatedly reintroduced from an external source. Plague lineages descended from the pestis secunda, however, are thought to have persisted in non-human reservoirs outside Europe, where they eventually gave rise to the Third Pandemic (19th and 20th centuries). Resolution of competing hypotheses on the origins of the many post-Black Death outbreaks has been hindered in part by the low representation of Y. pestis genomes in archaeological specimens, especially for the pestis secunda. Here we report on five individuals from Germany that were infected with lineages of plague associated with the pestis secunda. For the two genomes of high coverage, one groups within the known diversity of genotypes associated with the pestis secunda, while the second carries an ancestral genotype that places it earlier. Through consideration of historical sources that explore first documentation of the pandemic in today's Central Germany, we argue that these data provide robust evidence to support a post-Black Death evolution of the pathogen within Europe rather than a re-introduction from outside. Additionally, we demonstrate retrievability of Y. pestis DNA in post-cranial remains and highlight the importance of hypothesis-free pathogen screening approaches in evaluations of archaeological samples.

Indexed as

PlagueYersinia pestisDNA, BacterialEuropeGenome, BacterialHumansPhylogenyDNA, Bacterial

Identifiers

PMID37463152
PMCPMC10414589
OpenAlexW4384663096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.